Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 2/20 | 0.73 |
| ▸ | TSHR | P16473 | 1/20 | 0.73 |
| ▸ | PLA2G4B | P0C869 | 6/20 | 0.71 |
| ▸ | RARB | P10826 | 3/20 | 0.67 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.63 |
| ▸ | GAA | P10253 | 2/20 | 0.61 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.61 |
| ▸ | THRA | P10827 | 2/20 | 0.60 |
| ▸ | THRB | P10828 | 2/20 | 0.60 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5053280 | 1.00 | TP53 (0.73) | TP53TSHRPLA2G4BRARBPLA2G4A | |
| SCHEMBL1019300 | 1.00 | TP53 (0.73) | TP53TSHRPLA2G4BRARBPLA2G4A | |
| SCHEMBL2387345 | 1.00 | TP53 (0.73) | TP53TSHRPLA2G4BRARBPLA2G4A | |
| SCHEMBL2399489 | 1.00 | TP53 (0.73) | TP53TSHRPLA2G4BRARBPLA2G4A | |
| SCHEMBL1022325 | 1.00 | TP53 (0.73) | TP53TSHRPLA2G4BRARBPLA2G4A | |
| SCHEMBL8728342 | 1.00 | TP53 (0.73) | TP53TSHRPLA2G4BRARBPLA2G4A | |
| SCHEMBL9161795 | 1.00 | TP53 (0.73) | TP53TSHRPLA2G4BRARBPLA2G4A | |
| SCHEMBL10045771 | 1.00 | TP53 (0.73) | TP53TSHRPLA2G4BRARBPLA2G4A | |
| SCHEMBL4209056 | 1.00 | TP53 (0.73) | TP53TSHRPLA2G4BRARBPLA2G4A | |
| SCHEMBL1023839 | 0.98 | TP53 (0.70) | TP53TSHRPLA2G4BRARBPLA2G4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119751462-A | Benzotriazine diradical compound, preparation method and application thereof in organic resistive random access memory, near infrared detector and temperature control film | 郑州大学 | 2025-04-04 | — | — | CN | disclosed |
| CN-115677721-B | Benzotriazine free radical compound, preparation method thereof and application thereof in organic memory | 郑州大学 | 2023-11-24 | — | — | CN | disclosed |
| CN-115677721-A | Benzotriazine free radical compound, preparation method thereof and application thereof in organic memory | 郑州大学 | 2023-02-03 | — | — | CN | disclosed |
| US-20190292215-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF DISEASE | SPEROVIE BIOSCIENCES, INC. | 2019-09-26 | — | — | US | disclosed |
| EP-3484504-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF DISEASE | Sperovie Biosciences, Inc. (US) | 2019-05-22 | — | — | EP | disclosed |
| WO-2018013908-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF DISEASE | SPEROVIE BIOSCIENCES, INC. (US) | 2018-01-18 | — | — | WO | disclosed |
| WO-2018013887-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF DISEASE | SPEROVIE BIOSCIENCES, INC. (US) | 2018-01-18 | — | — | WO | disclosed |
| EP-1087946-B1 | ARYL ALKANOYLPYRIDAZINES | MERCK PATENT GMBH (DE) | 2007-01-10 | — | — | EP | disclosed |
| US-6417188-B1 | ENZYME INHIBITORS OF PHOSPHODIESTERASE | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 2002-07-09 | — | — | US | disclosed |
| EP-0684246-B1 | Optically active tetrahydropyran derivative, liquid crystal composition, and liquid crystal device containing the same | KASHIMA OIL (JP) | 2001-10-17 | — | — | EP | disclosed |
| EP-0241518-A1 | SYNTHESIS OF NEW LIQUID CRYSTAL MATERIALS POSSESSING PHENYLBENZOATE OR BIPHENYL CORE UNITS AND (2,3)-EPOXYALKYLOXIRANEMETHANOL CHIRAL TAILS | UNIVERSITY PATENTS, INC. (US) | 1987-10-21 | — | — | EP | disclosed |
| EP-0240184-A2 | Alpha-Methylcinnamic acid ester derivative and liquid crystal composition | MITSUBISHI RAYON CO., LTD. (JP) | 1987-10-07 | — | — | EP | disclosed |
| US-4695650-A | Liquid crystal compounds and compositions containing same | UNIVERSITY OF COLORADO FOUNDATION (US) | 1987-09-22 | — | — | US | disclosed |
| US-4668829-A | HIGH SPEED ELECTRO-OPTIC SWITCHES, PROPYLENE-1,2-GLYCOL DERIVATIVES | UNIVERSITY PATENTS, INC. (US) | 1987-05-26 | — | — | US | disclosed |
| WO-1987002036-A1 | SYNTHESIS OF NEW LIQUID CRYSTAL MATERIALS POSSESSING PHENYLBENZOATE OR BIPHENYL CORE UNITS AND (2,3)-EPOXYALKYLOXIRANEMETHANOL CHIRAL TAILS | UNIVERSITY PATENTS, INC. (US) | 1987-04-09 | — | — | WO | disclosed |
| US-4638073-A | Synthesis of new liquid crystal materials possessing phenylbenzoate or biphenyl core units and (2,3)-epoxyalkyloxiranemethanol chiral tails | UNIVERSITY PATENTS, INC. | 1987-01-20 | — | — | US | disclosed |
| EP-0188222-A2 | Novel liquid cristalline compounds having substituents | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1986-07-23 | — | — | EP | disclosed |
| US-4576732-A | OPTICAL DISPLAYS | HITACHI, LTD. (JP) | 1986-03-18 | — | — | US | disclosed |
| US-4556727-A | Ferroelectric smectic liquid crystals | UNIVERSITY PATENTS, INC. (US) | 1985-12-03 | — | — | US | disclosed |
| EP-0110299-A2 | Smectic liquid crystal compounds and liquid crystal compositions | HITACHI, LTD. (JP) | 1984-06-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190292215-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF DISEASE | STING1, CGAS, MYD88 | TP53 138/4885TSHR 2819/4885PLA2G4B 128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.